Dr. Samuel Thomas Connolly

The recognized brand name medications Zepbound™ and Mounjaro® are manufactured by Eli Lilly and Company™. The brand name medications Wegovy® and Ozempic® are manufactured by Novo Nordisk A/S. Willow does NOT manufacture or distribute these medications and has no direct affiliation with Eli Lilly and Company™ or Novo Nordisk A/S.

The products offered by Willow are compounded medications prepared by licensed compounding pharmacies. These formulations are not approved by the U.S. Food and Drug Administration (FDA) and have not undergone clinical trials to evaluate their safety, efficacy, or therapeutic equivalence to any FDA-approved medications. They are not intended to diagnose, treat, cure, or prevent any disease and are not substitutes for FDA-approved medications such as MOUNJARO®, ZEPBOUND™, Wegovy®, or Ozempic®. Any claims regarding effectiveness, safety, or weight loss benefits relate only to general mechanisms of the active ingredients (e.g., tirzepatide or semaglutide) and do not pertain to Willow's specific compounded formulations. These products are not approved for cosmetic weight loss and should only be used under the supervision of a licensed healthcare provider. By purchasing or using these products, you acknowledge and accept these terms. Product image for illustration only. Willow is not the compounder or manufacturer.